ArticleFrontiers in physiology2021

Silencing of miR-150-5p Ameliorates Diabetic Nephropathy by Targeting SIRT1/p53/AMPK Pathway.

Wenmin Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.